annual review 2015 oriolakd brief year 2015 content oriolakd improves people wellbeing ensuring pharmaceu tical consumer health product delivered safe cu tomerfriendly manner pharmacy oriolakd offer expert 2 oriolakd brief advice health wellbeing extensive highquality selection product company offer operator health 3 key figure care sector extensive selection service oriolakd provides effective reliable link pharmaceutical company 4 key event consumer sweden finland estonia latvia lithuania 5 ceo review oriolakd long experience strong position finnish swedish pharmaceutical market 2015 oriolas market share 6 business review finnish pharmaceutical wholesale business 46 per cent sweden share 39 per cent 8 strategy changing business environment pharmaceutical wholesale business 19 per cent 10 information shareholder retail business source aty oriolakd swedish pharmacy association 11 board director group management team oriolakd corporation listed nasdaq helsinki ltd exchange 326 invoicing eur billion 163net sale eur billion 608 626 2353 number personnel operating profit excluding operating profit sweden 778 finland nonrecurring item eur million baltic country eur million 222 improve people wellbeing ensuring pharmaceutical consumer health product delivered safe customer friendly manner oriolakd provides effective reliable link pharmaceutical company consumer oriolakd operates sweden finland baltic country 2 key figure year 2015 invoicing eur million net sale eur million 16263 16197 16123 32622 15218 14567 30737 30601 29512 29029 2011 2012 2013 2014 2015 2011 2012 2013 2014 2015 operating profit excluding nonrecurring item eur million net cash flow operating activity 1 608 856 591 461 370 291 281 298 258 108 2011 2012 2013 2014 2015 2011 2012 2013 2014 2015 1 includes net cash flow disposed russian business 30 november 2014 3 key event year 2015 right issue updated strategy new operating model successful right issue oriolakd shareholder raised approxi meet challenge changing business environment mately eur 756 million gross asset improve service customer oriolakd reshaped operating model updated strategy longterm financial target 2016 major cooperation agreement acquisition svensk do december oriolakd signed agreement acquire svensk do finland oriolakd renewed longterm cooperation agreement company specialising pharmaceutical dose dispensing tran abbott orion boehringer ingelheim msd orifarm saction completed 8 february 2016 acquisition svensk sweden cooperation agreement purchasing logistics do open important path b2b healthcare market signed apoteksgruppen lloyd also boost oriolakds growing range service healthcare operator new pharmacy concept sweden positive development profitability oriolakds new web shop swedish consumer opened year 2015 succesful many way invoicing indicating september product range cover entire selection business volume increased cash flow strong kronans apotek pharmacy chain oriolakd also launched new care beauty pharmacy concept sweden 4 ceo review year 2015 2015 three main goal develop model ensure even higher level service customer oriolakd change help u become united digital channel expand b2b healthcare efficient company according new operating model market improve efficiency exploiting oriolakds business divided three business area group synergy succeeded well achie operating segment 1 january 2016 consumer service healthcare vement main goal year successful many way new operating model first quarter completed successful eur 756 million right issue strengthen balance sheet right issue ensures competitiveness enabled u redeem eur 40 million hybrid bond early excellent cash flow meant gearing ratio fell good write 2016 look like similar 2015 many way level year finnish swedish authority already decided cur rently discussing measure reduce healthcare cost successful launch threat opportunity oriolakd however far con vinced opportunity necessary reform healthcare online business structure new digital business model offer oriolakd 2016 three main goal sweden launched new web shop september web shop product range cover entire selection kronans 1 active development digital business apotek pharmacy chain sale new channel started 2 successful execution efficiency improving strategic deve expected form increasingly important area lopment initiative consumer business future shop finland baltic country successful sale grew considerably 3 development healthcare business 2015 sale profitability good swedish operation eero hautaniemi mainly due increase sale traded good president ceo otc product challenge faced considerable decline parallel import price reduction certain phar maceuticals negative impact gross margin finland signed several longterm agreement major customer first half year renewed coope ration agreement abbott orion boehringer ingelheim second half msd orifarm sweden renewed cooperation agreement purchasing logistics apoteksgruppen lloyd expansion healthcare market december signed agreement acquire svensk do company specialising pharmaceutical dose dispensing transa ction completed 8 february 2016 acquisition svensk do open important path u b2b healthcare market also boost range service healthcare operator growing according plan august announced updated strategy new operating model longterm financial target support strategy investment made increase operational efficiency strengthen market position oriolakds board director decided additional investment eur 20 million update group system increase efficiency logistics centre mankkaa investment decided made following three year new operating 5 business review year 2015 2015 oriolakds business divided two business segment pharmaceutical trade sweden pharmaceutical trade finland baltic country pharmaceutical trade sweden profitability swedish retail business supported growth sale otc pharmaceutical consumer health product management cost structure operating profit adversely affected significant decline parallel import pharmaceutical price reduction implement ed swedish authority fourth quarter 2014 second quarter 2015 increased sale new expensive prescription medicine low margin negatively affected relative profitability swedish retail business oriolakd launched web shop sweden 16 september 2015 planned 2015 oriolakd opened 5 new kronans apotek pharmacy sweden oriolakd total 309 pharmacy end 2015 otc consumer health product made 2627 total sale end 2015 new agreement pharmaceutical company made 2014 improved efficiency supported positive performance swedish wholesale business first quarter oriolakd renewed cooperation agree ments purchasing logistics apoteksgruppen lloyd operating profit excluding nonrecurring item eur million sweden finland baltic country 104 126 338 339 42 203 205 195 193 188 196 38 55 115 40 2011 2012 2013 2014 2015 2011 2012 2013 2014 2015 wholesale retail 6 business review year 2015 invoicing eur million sweden finland baltic country 16612 15266 15093 14245 14014 11637 10504 11210 11071 11050 7575 7693 6765 4856 5070 2011 2012 2013 2014 2015 2011 2012 2013 2014 2015 wholesale retail net sale eur million sweden finland baltic country 7693 7612 7434 6165 6367 7442 7528 6696 4830 5025 4605 4359 4364 4148 4253 2011 2012 2013 2014 2015 2011 2012 2013 2014 2015 wholesale retail pharmaceutical trade finland baltic country finnish wholesale business oriolakd renewed significant longterm cooperation agreement abbott orion boehrin ger ingelheim msd orifarm sale growth experienced key pharmaceutical company custo mers finnish wholesale business boosted positive trend wholesale invoicing service sale pharmaceutical company performed well oriolashopfis sale growth supported increase consumer health net sale profitability consumer health business declined relation comparison period however due continued tough com petition resulting increasing discount 7 strategy changing business environment year 2015 oriolakds different customer group core updated strategy customer new operating model evident form improved customer experience benefit people become interested health access market improves people wellbeing ensuring living longer also spending money wellbeing pharmaceutical consumer health product service consumer demanding willing use technology delivered safe customerfriendly manner service available 247 retail business becoming increa singly digital electronic service becoming necessity oriolakd meeting business environment challenge pharmaceutical market undergoing radical change role various operator changing new kind market partici expanding traditional pharmaceutical distribution service pant emerging market consolidates pharmaceutical pharmaceutical company retail trade company specialising focusing core business offering pharmaceutical company single point access nordic digitalisation impact operator need elect pharmaceutical market ronic service growing change increasing demand developing online service service business part new service strategy consumer business percentage elderly people rapidly growing offering pharmaceutical service healthcare sector inclu leading increasing healthcare need change creating new ding hospital business opportunity public private healthcare offering excellent customer experience product assort sector ment improving efficiency enhance competitiveness strategy changing business environment customer oriolakd help consumer enhance wellbeing pharmacy oriolakd offer expert advice health wellbeing oriolakd important role healthcare value chain orio extensive highquality selection product oriolakd lakd provides service healthcare operator pharmaceutical com offer extensive range service operator healthcare panies pharmacy hospital hospital district clinic veterinarian sector sweden finland baltic country company grocery help customer succeed oriolakd offer unites consumer pharmaceutical company unique way consumer expert advice health wellbeing extensive oriolakd provides pharmaceutical company effective highquality selection product pharmacy 8 strategy changing business environment year 2015 new business area longterm financial target meet challenge changing business environment business growth rate market improve service customer oriolakd reshaping annual eps growth 5 per cent without nonrecurring item operating model 1 january 2016 oriolakds business divided three business area operating segment return capital employed 20 per cent consumer service healthcare adjusted gearing ratio 3060 per cent nonrecourse trade receivables added net debt consumer business focus need product service consumer health wellbeing service business offer tailored service pharmaceutical company pharmacy grocery store veterinarian healthcare business offer service hospital healthcare centre healthcare operator one face towards improve people wellbeing ensuring pharmaceutical consumer touch health product delivered safe customerfriendly manner pharmaceutical industry local consumer oriolakd value open work together take initiative take responsibility 9 information shareholder year 2015 profit period eur million total yield bshare 50 465 40 445 30 343 361 320 20 184 10 223 0 171 171 10 20 cagr 5y 112 20112015 701 30 404 40 2011 2012 2013 2014 2015 50 2011 2012 2013 2014 2015 net sale operating profit excluding nonrecurring item b oriolakd bshare price development 11201531122015 eur 20142015 eur million 45 b 332 304 4 11767 11834 35 335 337 3 7663 7771 15 15 15 01 5 bosake 2014 2015 2014 2015 20 20 20 2 omx helsinki cap suhteellinen 11 14 17 1 10 oriolakd bshare omx helsinki cap pi rebased service business consumer business major shareholder 31 december 2015 dividend earnings per share eur total total 030 029 share vote 10114 11114 12114 1115 2115 3115 4115 5115 6115 7115 8115 9115 10115 11115 12115 8114 9114 025 1 mariatorp oy 777 806 025 2 wipunen varainhankinta oy 485 463 020 3 ilmarinen mutual pension insurance company 419 616 015 015 013 4 varma mutual pension insurance company 418 726 011 011 5 mandatum life insurance company limited 251 185 010 009 008 6 fondita nordic micro cap 187 028 003 004 005 7 fennia life insurance company ltd 153 070 005 005 000 000 000 8 medical investment trust ltd 114 257 2011 2012 2013 2014 2015 9 maa ja vesitekniikan tuki ry 113 330 dividend repayment equity 10 social insurance institution finland kela 110 016 earnings per share proposal board director 10 board director group management team year 2015 board director 20142015 anssi vanjoki jukka alho per båtelson anja korhonen chairman board vice chairman msc physic b 1950 chairman audit committee msc economics b 1956 chairman remuneration committee independent member board since 2010 msc economics b1953 independent member board since 2015 msc eng b 1952 independent member board since 2014 independent member board since 2011 kuisma niemelä eva nilsson bågenholm matti rihko staffan simberg msc b 1958 physician b 1960 msc economics msc psychology b 1962 mba b 1949 independent member board since 2014 independent member board since 2015 independent member board since 2014 independent member board since 2015 group management team 31 december 2015 eero hautaniemi sari aitokallio lars birkeland thomas gawell president ceo cfo vice president consumer business vice president healthcare business sc econ b 1965 master law b 1960 msc econ b 1964 msc econ b 1963 employed oriolakd since 2006 employed oriolakd since 2015 employed oriolakd since 2012 employed oriolakd since 2001 investor relation sari aitokallio cfo 358 10 429 2112 sariaitokalliooriolakdcom eero hautaniemi president ceo jukka mäkelä teija silver kimmo virtanen 358 10 429 2109 vice president development information vice president human resource executive vice president service business management deputy ceo oriolakd corporation eerohautaniemioriolakdcom msc econ b 1964 sc b 1963 sc econ b 1968 employed oriolakd since 2006 employed oriolakd since 2013 employed oriolakd since 2006 iroriolakdcom wwworiolakdcominvestors 11 oriolakd corporation orionintie 5 po box 8 fi02101 espoo wwworiolakdcom 12